Skip to main content
. 2022 Sep 29;12:1005571. doi: 10.3389/fonc.2022.1005571

Figure 2.

Figure 2

Kaplan-Meier overall survival curves of HCC patients receiving TACE therapy, stratified by sarcopenia. HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.